维普期刊资源整合服务平台（V6.5）

维普中文期刊产品整合服务

6篇 您的检索式：作者名="Intermesoli T"

选中清除导出查看参考文献查看引证文献引用追踪共1页首页上一页第1页下一页末页 /1 跳转

		题名	作者	年代	出处	被引量
	1	Results ofa lympho- blastic leukemia-like chemotherapy program with risk-adapted mediastinal irradiation and stem cell transplantation for adult patients with lymphoblastic lymphoma显示文摘	Cortelazzo S Intermesoli T Oldani E	2012	Ann Hematol2012，91，1：	1
	2	A phase II study on intensive ALL-type chemotherapy with minimal residual disease(MRD) oriented postremission strategy in adult patients with LBL(protocol NILG-ALL 09/00)显示文摘	Cortelazzo S Intermesoli T Oldani E	2008	Haematologica2008，1，：	1
	3	Results of a lympho- blasfic leukemia-like chemotherapy program with risk-adapted mediastinal irradiation and stem cell transplantation for adult pa- tients with lymphoblastic lymphoma显示文摘	Cortelazzo S Intermesoli T Oldani E	2012	Ann Hematol2012，91，1：	1
	4	Results of a lymphoblasticleukemia-like chemotherapy program with risk-adapted mediastinalirradiation and stem cell transplantation for adult patients withlymphoblasticlympiioma显示文摘	Cortelazzo S Intermesoli T Oldani E	2012	Ann Hematol2012，91，：	1
	5	A short low-dose imatinib trial allows rapid identification of responsive patients in hypereosinophilie syndromes显示文摘	Intermesoli T Delaini F Acerboni S	2009	Br J Haematol2009，147，5：	1
	6	CD20 expres- sion has no prognostic role in Philadelphia - negative B - precur- sor acute lymphoblastic leukemia: new insights from the molecu- lar study of minimal residual disease显示文摘	Mannelli F Gianfaldoni G Intermesoli T	2012	Haemalologica2012，97，4：	1

返回顶部每页显示：

共1页首页上一页第1页下一页末页 /1 跳转

goolge学术搜索-维普

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1　渝公网安备 50019002500403号　违法和不良信息举报中心

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费